Nulibry
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nulibry, covering 2021-02-26 to 2024-07-25. Get the full timeline:
Most recent: EMA Authorised: Nulibry (fosdenopterin hydrobromide dihydrate) — TMC Pharma (EU) Limited